[1. G. Lavanya, V. Padmavathi and A. Padmaja, Synthesis and antioxidant activity of 1,4-[bis(3-arylmethanesulfonyl pyrrolyl and pyrazolyl)]benzenes, J. Braz. Chem. Soc. 25 (2014) 1200–1207; https://doi.org/10.5935/0103-5053.2014009710.5935/0103-5053.20140097]Search in Google Scholar
[2. S. Durgamma, A. Muralikrishna, V. Padmavathi and A. Padmaja, Synthesis and antioxidant activity of amido-linked benzoxazolyl/benzothiazolyl/benzimidazolyl-pyrroles and pyrazoles, Med. Chem. Res.23 (2014) 2916–2929; https://doi.org/10.1007/s00044-013-0884-x10.1007/s00044-013-0884-x]Search in Google Scholar
[3. S. K. Sridhar, M. Saravanan and A. Ramesh, Synthesis and antibacterial screening of hydrazones, Schiff and Mannich bases of isatin derivatives, Eur. J. Med. Chem.36 (2001) 615–625; https://doi.org/10.1016/S0223-5234(01)01255-710.1016/S0223-5234(01)01255-7]Search in Google Scholar
[4. S. I. Alqasoumi, M. M. Ghorab, Z. H. Ismail, S. M. Abdel-Gawad, M. S. El-Gaby and H. M. Aly, Novel antitumor acetamide, pyrrole, pyrrolopyrimidine, thiocyanate, hydrazone, pyrazole, isothiocyanate and thiophene derivatives containing a biologically active pyrazole moiety, Arzneimittelforschung59 (2009) 666–671; https://doi.org/10.1055/s-0031-129645710.1055/s-0031-129645720108654]Search in Google Scholar
[5. Y. Xia, C. Fan, B. X. Zhao, J. Zhao, D. S. Shin and J. Y. Miao, Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells, Eur. J. Med. Chem.43 (2008) 2347–2353; https://doi.org/10.1016/j.ejmech.2008.01.02110.1016/j.ejmech.2008.01.02118313806]Search in Google Scholar
[6. R. M. Mohareb, H. D. Fleita and O. K. Sakka, Novel synthesis of hydrazide-hydrazone derivatives and their utilization in the synthesis of coumarin, pyridine, thiazole and thiophene derivatives with antitumor activity, Molecules16 (2010) 16–27; https://doi.org/10.3390/molecules1601001610.3390/molecules16010016625941921187814]Search in Google Scholar
[7. A. A. El-Tombary and S. A. M. El-Hawash, Synthesis, antioxidant, anticancer and antiviral activities of novel quinoxalinehydrazone derivatives and their acyclic C-nucleosides, Med. Chem. 10 (2014) 521–532; https://doi.org/10.2174/1573406411309666006910.2174/1573406411309666006924151878]Search in Google Scholar
[8. M. O. Puskullu, H. Shirinzadeh, M. Nenni, H. Gurer-Orhan and S. Suzen, Synthesis and evaluation of antioxidant activity of new quinoline-2-carbaldehyde hydrazone derivatives: bioisosteric melatonin analogues, J. Enzyme Inhib. Med. Chem.31 (2016) 121–125; https://doi.org/10.3109/14756366.2015.100501210.3109/14756366.2015.100501225942363]Search in Google Scholar
[9. H. S. Kareem, A. Ariffin, N. Nordin, T. Heidelberg, A. Abdul-Aziz, K. W. Kong and W. Yehye, Correlation of antioxidant activities with theoretical studies for new hydrazone compounds bearing a 3,4,5-trimethoxy benzyl moiety, Eur. J. Med. Chem.103 (2015) 497–505; https://doi.org/10.1016/j.ejmech.2015.09.01610.1016/j.ejmech.2015.09.01626402727]Search in Google Scholar
[10. M. Georgieva, D. Tzankova, S. Vladimirova and A. Bijev, Evaluation of a group of pyrrole derivatives as tuberculostatic agents, CBU Int. Conf. Innov. Sci. Ed.5 (2017) 1083–1091; https://doi.org/10.12955/cbup.v5.107510.12955/cbup.v5.1075]Search in Google Scholar
[11. A. Bijev and M. Georgieva, Pyrrole-based hydrazones synthesized and evaluated in vitro as potential tuberculostatics, Lett. Drug Des. Discov.7 (2010) 430–437; https://doi.org/10.2174/15701800978910826810.2174/157018009789108268]Search in Google Scholar
[12. A. Kajal, S. Bala, N. Sharma, S. Kamboj and V. Saini, Therapeutic potential of hydrazones as anti-inflammatory agents, Int. J. Med. Chem.11 (2014) 1–11; https://doi.org/10.1155/2014/76103010.1155/2014/761030]Search in Google Scholar
[13. K. N. de Oliveira, P. Costa, J. R. Santin, L. Mazzambani, C. Bürger, C. Mora, R. J. Nunes and M. M. de Souza, Synthesis and antidepressant-like activity evaluation of sulphonamides and sulphonylhydrazones, Bioorg. Med. Chem.19 (2011) 4295–4306; https://doi.org/10.1016/j.bmc.2011.05.05610.1016/j.bmc.2011.05.056]Search in Google Scholar
[14. C. M. Leal, S. L. Pereira, A. E. Kummerle, D. M. Leal, R. Tesch, C. M. de Sant’Anna, C. A. Fraga, E. J. Barreiro, R. T. Sudo and G. Zapata-Sudo, Antihypertensive profile of 2-thienyl-3,4-methylene dioxy benzoylhydrazone is mediated by activation of the A2A adenosine receptor, Eur. J. Med. Chem.55 (2012) 49–57; https://doi.org/10.1016/j.ejmech.2012.06.05610.1016/j.ejmech.2012.06.056]Search in Google Scholar
[15. L. Yurttaş, Y. Özkay, Z. A. Kaplancıklı, Y. Tunalı and H. Karaca, Synthesis and antimicrobial activity of some new hydrazone-bridged thiazole-pyrrole derivatives, J. Enzyme Inhib. Med. Chem.28 (2013) 830–835; https://doi.org/10.3109/14756366.2012.68804310.3109/14756366.2012.688043]Search in Google Scholar
[16. O. O. Ajani, C. A. Obafemi, O. C. Nwinyi and D. A. Akinpelu, Microwave assisted synthesis and antimicrobial activity of 2-quinoxalinone-3-hydrazone derivatives, Bioorg. Med. Chem.18 (2010) 214–221; https://doi.org/10.1016/j.bmc.2009.10.06410.1016/j.bmc.2009.10.064]Search in Google Scholar
[17. R. J. Vaigunda, D. Sriram, S. K. Patel, I. V. Reddy, N. Bharathwajan, J. Stables and P. Yogeeswari, Design and synthesis of anticonvulsants from a combined phthalimide-GABA-anilide and hydra-zone pharmacophore, Eur. J. Med. Chem.42 (2007) 146–151; https://doi.org/10.1016/j.ejmech.2006.08.01010.1016/j.ejmech.2006.08.010]Search in Google Scholar
[18. J. R. Dimmock, S. C. Vashishtha and J. P. Stables, Anticonvulsant properties of various acetylhydra-zones, oxamoylhydrazones and semicarbazones derived from aromatic and unsaturated carbonyl compounds, Eur. J. Med. Chem.35 (2000) 241–248; https://doi.org/10.1016/S0223-5234(00)00123-910.1016/S0223-5234(00)00123-9]Search in Google Scholar
[19. B. G. Giménez, M. S. Santos, M. Ferrarini and J. P. S. Fernandes, Evaluation of blockbuster drugs under the Rule-of-five, Pharmazie65 (2010) 148–152; https://doi.org/10.1691/ph.2010.9733]Search in Google Scholar
[20. C. A. Lipinski, Lead- and drug-like compounds: the rule-of-five revolution, Drug Discov. Today Technol.1 (2004) 337–341; https://doi.org/10.1016/j.ddtec.2004.11.00710.1016/j.ddtec.2004.11.00724981612]Search in Google Scholar
[21. T. P. Kenakin, Pharmacology in Drug Discovery and Development, 2nd ed., Elsevier, Amsterdam 2017, pp. 157–191.10.1016/B978-0-12-803752-2.00007-7]Search in Google Scholar
[22. J. F. Varghese, R. Patel and U. C. S. Yadav, Novel insights in the metabolic syndrome-induced oxidative stress and inflammation-mediated atherosclerosis, Curr. Cardiol. Rev.14 (2018) 4–14; https://doi.org/10.2174/1573403X1366617100911225010.2174/1573403X13666171009112250587226028990536]Search in Google Scholar
[23. H. Yaribeygi, Y. Panahi, B. Javadi and A. Sahebkar, The underlying role of oxidative stress in neurodegeneration: A mechanistic review, CNS Neurol. Dis.-Drug Targets17 (2018) 207–215; https://doi.org/10.2174/187152731766618042512255710.2174/187152731766618042512255729692267]Search in Google Scholar
[24. L. A. Pham-Huy, H. He and C. Pham-Huy, Free radicals, antioxidants in disease and health, Int. J. Biomed. Sci.4 (2008) 89–96.10.59566/IJBS.2008.4089]Search in Google Scholar
[25. M. Chand, Rajeshwari, A. Hiremathad, M. Singh, M. A. Santos and R. S. Keri, A review on antioxidant potential of bioactive heterocycle benzofuran: Natural and synthetic derivatives, Pharmacol. Rep.69 (2017) 281–295; https://doi.org/10.1016/j.pharep.2016.11.00710.1016/j.pharep.2016.11.00728171830]Search in Google Scholar
[26. M. Miceli, E. Roma, P. Rosa, M. Feroci, M. A. Loreto, D. Tofani and T. Gasperi, Synthesis of benzofuran-2-one derivatives and evaluation of their antioxidant capacity by comparing DPPH assay and cyclic voltammetry, Molecules23 (2018) 710–726; https://doi.org/10.3390/molecules2304071010.3390/molecules23040710601762029561784]Search in Google Scholar
[27. A. A. Shanty, J. E. Philip, E. J. Sneha, M. R. P. Kurup, S. Balachandran and P. V. Mohanan, Synthesis, characterization and biological studies of Schiff bases derived from heterocyclic moiety, Bioorg. Chem.70 (2017) 67–73; https://doi.org/10.1016/j.bioorg.2016.11.00910.1016/j.bioorg.2016.11.00927894775]Search in Google Scholar
[28. A. A. Shanty and P. V. Mohanan, Heterocyclic Schiff bases as non toxic antioxidants: Solvent effect, structure activity relationship and mechanism of action, Spectrochim. Acta A192 (2018) 181–187; https://doi.org/10.1016/j.saa.2017.11.01910.1016/j.saa.2017.11.01929136583]Search in Google Scholar
[29. K. M. Khan, Z. Shah, V. U. Ahmad, M. Khan, M. Taha, F. Rahim, S. Ali, N. Ambreen, S. Perveen, M. I. Choudhary and W. Voelter, 2,4,6-Trichlorophenylhydrazine Schiff bases as DPPH radical and super oxide anion scavengers, Med. Chem.8 (2012) 452–461; https://doi.org/10.2174/157340641120803045210.2174/157340641120803045222530900]Search in Google Scholar
[30. N. Belkheiri, B. Bouguerne, F. Bedos-Belval, H. Duran, C. Bernis, R. Salvayre, A. Nègre-Salvayre and M. Baltas, Synthesis and antioxidant activity evaluation of a syringic hydrazones family, Eur. J. Med. Chem.45 (2010) 3019–3026; https://doi.org/10.1016/j.ejmech.2010.03.03110.1016/j.ejmech.2010.03.03120403645]Search in Google Scholar
[31. A. Guillouzo, Liver cell models in in vitro toxicology, Environ. Health Perspect.106 (Suppl. 2) (1998) 511–532; https://doi.org/10.1289/ehp.9810651110.1289/ehp.9810651115333859599700]Search in Google Scholar
[32. P. Ertl, B. Rohde and P. Selzer, Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties, J. Med. Chem.43 (2000) 3714–3717; https://doi.org/10.1021/jm000942e10.1021/jm000942e11020286]Search in Google Scholar
[33. D. F. Veber, S. R. Johnson, H. Y. Cheng, B. R. Smith, K. W. Ward and K. D. Kopple, Molecular properties that influence the oral bioavailability of drug candidates, J. Med. Chem.45 (2002) 2615–2623; https://doi.org/10.1021/jm020017n10.1021/jm020017n]Search in Google Scholar
[34. А. Bijev, Synthesis and preliminary screening of carbohydrazides and hydrazones of pyrrole derivatives as potential tuberculostatics, Arzneimittelforschung56 (2006) 96–103; https://doi.org/10.1055/s-0031-129670810.1055/s-0031-1296708]Search in Google Scholar
[35. B. C. Evans, C. E. Nelson, S. S. Yu, K. R. Beavers, A. J. Kim, H. Li, H. M. Nelson, T. D. Giorgio and C. L. Duvall, Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs, J. Vis. Exp.73 (2013) e50166; https://doi.org/10.3791/5016610.3791/50166]Search in Google Scholar
[36. W. Brand-Williams, M. E. Cuvelier and C. Berset, Use of a free radical method to evaluate antioxidant activity, LWT-Food Sci. Technol.28 (1995) 25–30; https://doi.org/10.1016/S0023-6438(95)80008-510.1016/S0023-6438(95)80008-5]Search in Google Scholar
[37. R. Re, N. Pellegrini, A. Proteggente, A. Pannala, M. Yang and C. Rice-Evans, Antioxidant activity applying an improved ABTS radical cation decolorization assay, Free Radic. Biol. Med.26 (1999) 1231–1237; https://doi.org/10.1016/S0891-5849(98)00315-310.1016/S0891-5849(98)00315-3]Search in Google Scholar
[38. O. H. Lowry, N. J. Rosebrough, A. L. Farr and R. J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265–275.10.1016/S0021-9258(19)52451-6]Search in Google Scholar
[39. D. Mansuy, A. Sassi, P. M. Dansette and M. Plat, A new potent inhibitor of lipid peroxidation in vitro and in vivo, the hepatoprotective drug anisyldithiolthione, Biochem. Biophys. Res. Commun. 135 (1986) 1015–1021; https://doi.org/10.1016/0006-291X(86)91029-610.1016/0006-291X(86)91029-6]Search in Google Scholar
[40. C. Deby and R. Goutier, New perspectives on the biochemistry of superoxide anion and the efficiency of superoxide dismutases, Biochem. Pharmacol. 39 (1990) 399–405; https://doi.org/10.1016/0006-2952(90)90043-K10.1016/0006-2952(90)90043-K]Search in Google Scholar
[41. H. Gao and X. Gao, Recent Progress in Blood-brain Barrier Transportation Research, in Brain Targeted Drug Delivery System – A Focus on Nanotechnology and Nanoparticulates, 1sted. Elsevier, Amsterdam 2019, pp. 469–481.]Search in Google Scholar
[42. Y. H. Zhao, M. H. Abraham, J. Lee, A. Hersey, C. N. Luscombe, G. Beck, B. Sherborne and I. Cooper, Rate-limited steps of human oral absorption and QSAR studies, Pharm. Res.19 (2002) 1446–1457.10.1023/A:1020444330011]Search in Google Scholar
[43. D. Schuster, C. Laggner and T. Langer, Why drugs fail – a study on side effects in new chemical entities, Curr. Pharm. Des. 11 (2005) 3545–3559; https://doi.org/10.2174/13816120577441451010.2174/13816120577441451016248807]Search in Google Scholar
[44. W. C. Maddrey, Drug-induced hepatotoxicity, J. Clin. Gastroenterol. 39 (2005) S83–S89; https://doi.org/10.1097/01.mcg.0000155548.91524.6e10.1097/01.mcg.0000155548.91524.6e]Search in Google Scholar
[45. J. Hou, W. Zhao, Z. N. Huang, S. M. Yang, L. J. Wang, Y. Jiang, Z. S. Zhou, M. Y. Zheng, J. L. Jiang, S. H. Li and F. N. Li, Evaluation of novel N-(piperidine-4-yl)benzamide derivatives as potential cell cycle inhibitors in HepG2 cells, Chem. Biol. Drug Des.86 (2015) 223–231; https://doi.org/10.1111/cbdd.1248410.1111/cbdd.12484]Search in Google Scholar
[46. P. Martins, J. Jesus, S. Santos, L. R. Raposo, C. Roma-Rodrigues, P. V. Baptista and A. R. Fernandes, Heterocyclic anticancer compounds: recent advances and the paradigm shift towards the use of nanomedicine’s tool box, Molecules20 (2015) 16852–16891; https://doi.org/10.3390/molecules20091685210.3390/molecules200916852]Search in Google Scholar
[47. S. Knasmüller, W. Parzefall, R. Sanyal, S. Ecker, C. Schwab, M. Uhl, V. Mersch-Sundermann, G. Williamson, G. Hietsch, T. Langer, F. Darroudi and A. T. Natarajan, Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens, Mutat. Res./Fund. Mol. Mech. Mutagen.402 (1998) 185–202; https://doi.org/10.1016/S0027-5107(97)00297-210.1016/S0027-5107(97)00297-2]Search in Google Scholar
[48. V. Mersch-Sundermann, S. Knasmüller, X. J. Wu, F. Darroudi and F. Kassie, Use of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents, Toxicology198 (2004) 329–340; https://doi.org/10.1016/j.tox.2004.02.00910.1016/j.tox.2004.02.009]Search in Google Scholar
[49. Y. Sıcak, E. E. Oruç-Emre, M. Öztürk, T. Taşkın-Tok and A. Karaküçük-Iyidoğan, Novel fluorine-containing chiral hydrazide-hydrazones: Design, synthesis, structural elucidation, antioxidant and anticholinesterase activity, and in silico studies, Chirality (2019) https://doi.org/10.1002/chir.23102; ahead of print.10.1002/chir.23102]Search in Google Scholar
[50. D. X. Tan, L. D. Chen, B. Poeggeler, L. C. Manchester and R. J. Reiter, Melatonin: a potent, endogenous hydroxyl radical scavenger, Endocr. J.1 (1993) 57–60.]Search in Google Scholar
[51. R. Reiter, L. Tang, J. J. Garcia and A. Munoz-Hoyos, Pharmacological actions of melatonin in oxygen radical pathophysiology, Life Sci.60 (1997) 2255–2271; https://doi.org/10.1016/S0024-3205(97)00030-110.1016/S0024-3205(97)00030-1]Search in Google Scholar
[52. R. Hardeland, Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance, Endocrine27 (2005) 119–130; https://doi.org/10.1385/ENDO:27:2:11910.1385/ENDO:27:2:119]Search in Google Scholar
[53. L. Deferme, J. J. Briedé, S. M. H. Claessen, D. G. J. Jennen, R. Cavill and J. C. S. Kleinjans, Time series analysis of oxidative stress response patterns in HepG2: a toxicogenomics approach, Toxicology306 (2013) 24–34; https://doi.org/10.1016/j.tox.2013.02.00110.1016/j.tox.2013.02.001]Search in Google Scholar